Table 1 Baseline characteristics of study participants
Characteristics | Early-onset CAD N = 1513 | Control N = 1513 | p-value |
|---|---|---|---|
General conditions | |||
 Age, year | 39.6 ± 4.4 | 39.0 ± 4.4 |  < 0.001 |
 Male, n (%) | 1444 (95.4) | 842 (55.7) |  < 0.001 |
 BMI, kg/m2 | 26.4 ± 3.5 | 23.6 ± 3.7 |  < 0.001 |
Body shape, n (%) |  |  |  < 0.001 |
 Normal | 342 (23.1) | 878 (59.6) |  |
 Overweight | 685 (46.3) | 386 (26.2) |  |
 Obesity | 451 (30.5) | 210 (14.2) |  |
 Heart rate | 78.0 ± 13.2 | 78.9 ± 13.5 | 0.06 |
 SBP, mmHg | 128.0 ± 19.1 | 122.7 ± 14.7 |  < 0.001 |
 DBP, mmHg | 81.2 ± 13.9 | 78.1 ± 10.8 |  < 0.001 |
Smoke, n (%) |  |  |  < 0.001 |
 Never | 382 (25.2) | 1288 (85.1) |  |
 Former | 308 (20.4) | 96 (6.3) |  |
 Current | 823 (54.4) | 129 (8.5) |  |
 Drink, n (%) | 662 (43.8) | 76 (5.0) |  < 0.001 |
Comorbidities, n (%) | |||
 Hypertension | 669 (44.2) | 377 (24.9) |  < 0.001 |
 DM | 376 (24.9) | 151 (10.0) |  < 0.001 |
 Dyslipidemia | 873 (57.7) | 592 (39.1) |  < 0.001 |
 Chronic kidney disease | 39 (2.6) | 21 (1.4) | 0.03 |
Laboratory results | |||
 TC, mmol/l | 4.3 ± 1.6 | 4.2 ± 0.8 | 0.002 |
 TG, mmol/l | 2.3 ± 1.7 | 1.7 ± 1.3 |  < 0.001 |
 HDL-C, mmol/l | 1.0 ± 0.5 | 1.2 ± 0.4 |  < 0.001 |
 LDL-C, mmol/l | 2.7 ± 1.5 | 2.3 ± 0.7 |  < 0.001 |
 Non-HDL-C, mmol/l | 3.4 ± 1.6 | 3.0 ± 0.8 |  < 0.001 |
 UA, mg/dl | 6.5 ± 1.7 | 5.4 ± 1.7 |  < 0.001 |
 Scre, mg/dl | 0.9 ± 0.3 | 0.8 ± 0.3 |  < 0.001 |
 eGFR, mL/min/1.73 m2 | 92.0 [82.1–103.6] | 90.4 [82.6–97.9] |  < 0.001 |
 FBG, mg/dl | 6.6 ± 2.8 | 5.3 ± 1.2 |  < 0.001 |
 HbA1c, % | 6.2 ± 1.7 | 5.4 ± 0.7 |  < 0.001 |
 TyG index | 9.2 ± 0.8 | 8.7 ± 0.7 |  < 0.001 |